MARKET

PBM

PBM

Psyence Biomedical Ltd.
NASDAQ
3.090
+0.280
+9.96%
After Hours: 2.890 -0.2 -6.47% 19:46 02/13 EST
OPEN
2.790
PREV CLOSE
2.810
HIGH
3.100
LOW
2.790
VOLUME
135.40K
TURNOVER
--
52 WEEK HIGH
74.94
52 WEEK LOW
2.535
MARKET CAP
3.16M
P/E (TTM)
-0.1556
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBM last week (0209-0213)?
Weekly Report · 19h ago
Psyence Biomedical board approves put option agreement with PsyLabs
TipRanks · 3d ago
PSYENCE BIOMED APPROVES PUT OPTION AGREEMENT WITH PSYLABS TO SECURE STRATEGIC SUPPLY AND STRENGTHEN COMMERCIALIZATION PATHWAY
Reuters · 3d ago
Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply
TipRanks · 3d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 3d ago
Psyence BioMed Secures Equity Option for Stake in PsyLabs
Reuters · 3d ago
Psychedelic: Clearmind reports additional CMND-100 safety results
TipRanks · 4d ago
Psyence Biomedical Settles Shareholder Dispute With KAOS Capital
TipRanks · 4d ago
More
About PBM
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Webull offers Psyence Biomedical Ltd stock information, including NASDAQ: PBM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBM stock methods without spending real money on the virtual paper trading platform.